As a research analyst, you are frequently tasked with evaluating a client’s portfolio that includes traditional endowment policies. A common request involves determining whether these policies actually perform as ‘investments’ or if they are merely expensive insurance covers. To model this, you must strip away the mortality risk premium from the total insurance premium to isolate the amount effectively allocated toward wealth creation. This method, often called ‘Buy Term and Invest the Difference,’ is the gold standard for separating insurance from investment in any rigorous financial plan.
When a client pays an endowment premium of ₹50,000, you cannot treat the entire amount as invested capital. You first identify the premium of a pure term policy providing an equivalent sum assured, say ₹10,000. By subtracting the term premium from the endowment premium, you identify the net investible cash flow—in this case, ₹40,000. This ₹40,000 is the actual annuity payment (PMT) that you plug into a financial calculator to solve for the Internal Rate of Return (IRR).
If the calculated IRR fails to beat inflation or a benchmark like a diversified mutual fund, the endowment product is essentially a negative-alpha investment.
Consider an analyst reviewing an endowment plan with a 20-year tenure and a maturity benefit of ₹20 lakh. After isolating the ₹40,000 annual investment component, the analyst discovers the effective yield is a modest 4.2%. Comparing this against an equity-linked savings scheme (ELSS) or an index fund, which historically yields significantly higher returns, clarifies the recommendation. The professional insight here is that the ‘guaranteed’ nature of the endowment often comes at the expense of a massive opportunity cost that clients rarely calculate themselves.
Applying this framework shifts the conversation from product features to utility. You are essentially testing if the insurance company is a better investment manager than a professional fund house. In the Indian market, where endowment policies often suffer from high mortality and administrative charges, this isolation technique almost always highlights the inefficient cost structure of traditional life insurance products compared to separate protection and investment vehicles.
Nuance
Check Your Understanding
An investor pays an annual premium of ₹60,000 for an endowment policy with a ₹50 lakh death benefit. A comparable term policy with the same death benefit costs ₹8,000 annually. When evaluating the endowment as an investment vehicle, what is the correct annual cash flow to use in an IRR calculation?
Why is the ‘Buy Term and Invest the Difference’ approach generally considered more transparent than purchasing an endowment plan?
This is a companion read for Section 2.3 — Types of Life Insurance Products from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.